Answers are grounded in this paper and cite their sources.
Maternal hypotension during spinal anesthesia for cesarean delivery can compromise uteroplacental perfusion and fetal acid base status. Phenylephrine is widely used but may reduce cardiac output, whereas norepinephrine may better preserve maternal hemodynamics. Prior systematic reviews focused mainly on maternal outcomes and remain inconclusive for neonatal metabolic effects due to pooled population heterogeneity. Following PRISMA guidelines we included randomized controlled trials that administered intravenous norepinephrine or phenylephrine (bolus or infusion or combination) during elective cesarean delivery under regional anesthesia. Unlike earlier meta-analyses that pooled multiple gestations, pre-eclampsia, and fetal compromise, this review restricted inclusion to low-risk, singleton pregnancies to minimize confounding. Outcomes included Apgar scores at 1 and 5 min, umbilical cord blood gases, umbilical lactate, neonatal resuscitation and mortality. After screening 690 records, 25 trials met the inclusion criteria. No significant differences were detected in 1-minute or 5-minute Apgar scores between norepinephrine and phenylephrine across administration methods (bolus, infusion, and combined regimens). Norepinephrine infusions yielded significantly higher umbilical venous pH (standardized mean difference [SMD] = 0.29, 95% CI 0.08–0.49; p = 0.01) and lower umbilical arterial lactate (SMD = − 0.42, 95% CI − 0.74 to − 0.09; p = 0.01) compared to phenylephrine infusions. No cases of neonatal resuscitation or mortality were reported in either group. In low-risk populations, no significant differences were detected in Apgar scores or other reported clinical neonatal outcomes between norepinephrine and phenylephrine. Norepinephrine infusion was associated with higher umbilical venous pH and lower umbilical arterial lactate, although clinical significance remains uncertain. Larger trials are warranted. This metaanalysis and systematic review was prospectively registered on PROSPERO CRD42021248482.
No takes yet. Share an insight, caveat, or question.
Hameed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: